BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Hepatitis C virus
1
Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions
12/6/2018 1:35:45 PM | Browse: 12 | Download: 2
2
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
11/27/2018 1:56:41 PM | Browse: 20 | Download: 8
3
Mononuclear phagocyte system in hepatitis C virus infection
11/27/2018 5:55:53 AM | Browse: 18 | Download: 2
4
Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments?
11/7/2018 2:30:08 AM | Browse: 32 | Download: 5
5
Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir
10/26/2018 11:38:21 AM | Browse: 30 | Download: 10
6
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
10/12/2018 5:32:21 AM | Browse: 36 | Download: 16
7
Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
9/27/2018 9:38:46 AM | Browse: 51 | Download: 44
8
Challenge of hepatitis C in Egypt and hepatitis B in Mauritania
9/27/2018 9:38:46 AM | Browse: 47 | Download: 35
9
Epidemiology of viral hepatitis in Somalia: Systematic review and meta-analysis study
9/14/2018 5:53:04 AM | Browse: 37 | Download: 5
10
Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis
8/27/2018 7:22:43 AM | Browse: 62 | Download: 18
11
Form confers function: Case of the 3’X region of the hepatitis C virus genome
8/13/2018 7:45:11 AM | Browse: 55 | Download: 21
12
Hepatitis C and renal transplantation in era of new antiviral agents
8/9/2018 8:05:57 AM | Browse: 60 | Download: 20
13
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
6/28/2018 2:47:35 AM | Browse: 110 | Download: 62
14
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
6/26/2018 12:26:34 AM | Browse: 88 | Download: 43
15
Hepatitis C virus infection in children in the era of direct-acting antiviral
6/26/2018 12:26:34 AM | Browse: 94 | Download: 36
16
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
4/4/2018 1:15:45 PM | Browse: 130 | Download: 38
17
Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
3/26/2018 8:48:04 AM | Browse: 112 | Download: 58
18
Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release
3/26/2018 8:48:04 AM | Browse: 87 | Download: 15
19
Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions
3/16/2018 12:27:25 PM | Browse: 132 | Download: 34
20
Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents
3/4/2018 12:36:47 PM | Browse: 99 | Download: 27
21
Hepatitis C virus: Morphogenesis, infection and therapy
3/4/2018 12:36:47 PM | Browse: 120 | Download: 48
22
High burden of hepatocellular carcinoma and viral hepatitis in Southern and Central Vietnam: Experience of a large tertiary referral center, 2010 to 2016
1/26/2018 8:09:36 AM | Browse: 152 | Download: 114
23
Role of inflammatory response in liver diseases: Therapeutic strategies
1/26/2018 8:09:36 AM | Browse: 155 | Download: 65
24
Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates
1/19/2018 9:46:49 AM | Browse: 168 | Download: 52
25
Hepatitis C virus core protein-induced miR-93-5p inhibits IFN signaling pathway through targeting IFNAR1
1/14/2018 5:07:58 AM | Browse: 145 | Download: 90
26
Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas
1/7/2018 4:21:05 AM | Browse: 179 | Download: 68
27
Estrogen, estrogen receptors, and hepatocellular carcinoma: are we there yet?
1/7/2018 4:21:04 AM | Browse: 150 | Download: 53
28
Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
12/27/2017 10:31:19 AM | Browse: 157 | Download: 53
29
Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
12/12/2017 8:34:13 AM | Browse: 153 | Download: 45
30
Global elimination of hepatitis C virus infection: Progresses and the remaining challenges
11/24/2017 12:22:15 AM | Browse: 211 | Download: 93
31
Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
8/28/2017 6:54:48 AM | Browse: 252 | Download: 294
32
(-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes
8/28/2017 6:54:48 AM | Browse: 186 | Download: 248
33
Lurking epidemic of hepatitis C virus infection in Iran: A call to action
8/25/2017 1:53:29 AM | Browse: 181 | Download: 125
34
Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
8/19/2017 11:33:53 AM | Browse: 127 | Download: 147
35
Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model
7/28/2017 8:16:18 AM | Browse: 156 | Download: 618
36
Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study
7/17/2017 11:13:33 PM | Browse: 151 | Download: 187
37
Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease
7/5/2017 4:40:07 AM | Browse: 192 | Download: 296
38
Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C
6/7/2017 7:22:42 AM | Browse: 494 | Download: 1255
39
Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients
5/12/2017 10:16:48 PM | Browse: 220 | Download: 450
40
Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection
4/13/2017 3:45:15 PM | Browse: 221 | Download: 366
41
Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients
4/13/2017 3:45:15 PM | Browse: 239 | Download: 233
42
Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
3/24/2017 9:18:00 AM | Browse: 340 | Download: 601
43
Mortality associated with hepatitis C and hepatitis B virus infection: A nationwide study on multiple causes of death data
3/13/2017 7:05:00 PM | Browse: 314 | Download: 398
44
Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C
3/13/2017 1:20:00 PM | Browse: 266 | Download: 539
45
Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review
3/6/2017 1:27:00 PM | Browse: 348 | Download: 404
46
Autoantibody profiles in autoimmune hepatitis and chronic hepatitis C identifies similarities in patients with severe disease
2/26/2017 6:20:00 PM | Browse: 304 | Download: 733
47
Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment
2/26/2017 6:20:00 PM | Browse: 257 | Download: 298
48
Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data
2/17/2017 8:32:00 AM | Browse: 266 | Download: 219
49
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection
2/6/2017 9:08:00 AM | Browse: 226 | Download: 373
50
Hepatitis C virus-associated pruritus: Etiopathogenesis and therapeutic strategies
1/22/2017 11:39:00 AM | Browse: 291 | Download: 539